No association between ApoE and schizophrenia: Evidence of systematic review and updated meta-analysis

Schizophr Res. 2015 Dec;169(1-3):355-368. doi: 10.1016/j.schres.2015.08.031. Epub 2015 Sep 12.

Abstract

Introduction: Schizophrenia affects between 0.3% and 2% of the worldwide population. A genetic contribution has been postulated in the development of this disorder. Genes such as ApoE have been implicated in the neurodevelopment associated with schizophrenia in case-control and meta-analysis studies, but the results remain inconclusive. Due to this, the aim of the present study was to explore the association between ApoE and schizophrenia through a meta-analysis.

Material and methods: We collected all relevant studies by searching PubMed and EBSCO databases. The pooled odds ratios with 95% confidence intervals were calculated to estimate the association. The following models were evaluated: A) ε4 vs ε3, B) ε4 vs ε2, C) ε4 vs ε3+ε2, D) Caucasian population and E) Asian population. Statistical analyses were performed using EPIDAT 3.1 software.

Results: The meta-analyses comprised 28 association studies, which included 4703 controls and 3452 subjects with schizophrenia. A significant protective effect was found for allele ε3 in the Asian population (OR=0.73, 95% CI=0.54-0.98). No significant associations were observed in the other models and populations analyzed.

Conclusions: Our meta-analysis suggests a protective association between ApoE allele ε3 and schizophrenia in the Asian population.

Keywords: ApoE gene; Meta-analysis; Schizophrenia; Systematic review.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't
  • Review
  • Systematic Review

MeSH terms

  • Apolipoproteins E / genetics*
  • Databases, Bibliographic / statistics & numerical data
  • Humans
  • Schizophrenia / genetics*

Substances

  • Apolipoproteins E